Analyst Ratings for Elevation Oncology (ELEV)
ELEV Rating Summary
ELEV Price Target Summary
- Highest: $8.00 (Leerink Partners)
- Lowest: $6.00 (H.C. Wainwright)
- Average: $7.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.25 (+41.3%)
* Over Last 12-Mos
Rating Score: 8.3 / 10 Percentile Rank: 86%
Rating Score: 8.3 / 10 Percentile Rank: 86%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/1/2024 | JMP Securities | Silvan Tuerkcan | New Coverage | Market Outperform (N/A) |
7.00 (N/A) |
3.85 (5.13) |
33.25% | Details |
9/29/2023 | H.C. Wainwright » Updated 2/20/2024 |
Swayampakula Ramakanth | New Coverage | Buy (N/A) |
6.00 (1.50) |
0.68 (5.13) |
654.41% | Details |